Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Market watchers are anticipating strong results driven by the robust https://kathryncwll793541.slypage.com/37869221/analyzing-eli-lilly-s-q3-results